Crown Laboratories Acquires Revance Therapeutics, Expanding Aesthetic Portfolio
The deal expands Crown’s presence in the aesthetics market, bringing Daxxify and the RHA Collection into its portfolio.
The deal expands Crown’s presence in the aesthetics market, bringing Daxxify and the RHA Collection into its portfolio.
Researchers evaluated a proprietary dual hyaluronic acid complex designed to promote tissue remodeling through biomaterial-based regenerative biostimulation rather than localized inflammation.